US pharma giant Eli Lilly has warned that planning processes are an “impediment” to investing in the UK and must change if the country is to compete on the global stage.
Chief executive Dave Ricks told the BBC that
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
